A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis

NCT00106847 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

683

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Parapsoriasis

Interventions

DRUG: Infliximab

Sponsor

Centocor, Inc.